Last reviewed · How we verify
NCT04054141
rTMS in Treatment of Spasticity
NA trial testing Mag Stim in ALS in 3 participants. Terminated before completion.
16 August 2022
Quick facts
| Lead sponsor | Hospital for Special Surgery, New York |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 3 |
| Start date | 1 September 2018 |
| Primary completion | 16 August 2022 |
| Estimated completion | 16 August 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Mag Stim
Conditions studied
- ALS — all drugs for ALS →
Sponsor
Hospital for Special Surgery, New York
Who can join
18 and older, any sex, with ALS. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an open-label clinical trial to determine the safety and efficacy of rTMS in reducing spasticity and improving quality of life among patients with upper motor neuron predominant motor neuron disease (MND).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04054141
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ALS
Currently open trials in the same condition.
- NCT07460037 — Chinese-Specific Speech Imagery Coding Using High-Density ECoG · NA · recruiting
- NCT07006571 — At-home Treatment With Cortico-spinal tDCS for Amyotrophic Lateral Sclerosis · NA · recruiting
- NCT07193953 — Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS) · Phase 1 · recruiting
- NCT06735014 — Multicenter ALS Imaging Study · recruiting
- NCT06511934 — Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01) · NA · recruiting
Other Hospital for Special Surgery, New York trials
Trials by the same sponsor.
- NCT07226700 — Suzetrigine in Total Hip Arthroplasty · Phase 3 · recruiting
- NCT06567873 — Gastric Ultrasound Assessment for Patients Taking Cannabis · completed
- NCT07217964 — Natural Matrix Protein · enrolling by invitation
- NCT06798493 — CSS-SR Validation Study · enrolling by invitation
- NCT06180486 — Mindfulness Meditation Intervention Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04054141 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital for Special Surgery, New York
- Last refreshed: 14 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04054141.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing